Asia Pacific Western Blotting Market to amass $210.92 Mn by 2027

December 10, 2019


According to the latest study titled ‘Asia Pacific Western Blotting Market to 2027 - Regional Analysis and Forecasts by Product (Instruments, Consumables); Application (Biomedical & Biochemical Research, Agriculture and Others); End User (Biotechnological and Pharmaceutical Companies, Diagnostic Laboratories, Academic and Research Institutes), and Country’ available with Market Study Report LLC, Asia Pacific western blotting market is estimated to accumulate US $210.92 million by the year 2027.
 

The method of western blotting is used to identify and measure the amount of a specific protein in a mixed extract. Factors aiding the growth of Asia Pacific western blotting market are increasing initiatives by private and government bodies, expansion of biotechnology industry, and automation in western blot techniques. Rising prevalence of diseases like Lyme and HIV, coupled with the need for effective diagnosis and improved treatment is further augmenting the market outlook.
 

According to the study, Asia Pacific western blotting market was worth US $128.2 million in 2018 and is anticipated to register a growth rate of 5.9% over the analysis period. The study encompasses details about market size based on revenue shares for each segment, alongside the expansion strategies adopted by manufacturers. Information about the market dynamics covering drivers and restraints is also outlined in the report.  
 

Based on product, Asia pacific western blotting market from consumables segment registered the largest share in 2018 and is presumed to continue its dominance in the upcoming years, owing to its reusability and increasing R&D and clinical activities, cites the report.
 

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2202062/
 

As per application spectrum, biomedical & biochemical research segment led Asia Pacific western blotting market in 2018. While speaking of end-user scope, Asia Pacific western blotting market from academic & research institutes segment is presumed to register accelerated expansion over the forecast timeline, owing to increasing number of biotechnology institutes across the region.
 

Some of the vendors that operate in Asia Pacific western blotting market are Abcam Plc., Rockland Immunochemicals, Inc., OriGene Technologies, Inc., LI-COR, Inc., Bio-Rad Laboratories, Inc., Perkin Elmer, Inc., Cell Signaling Technology, Inc., General Electric, Merck KGaA, and Thermo Fisher Scientific, Inc.


Frequently Asked Questions (FAQ) :

Factors propelling the growth of Asia Pacific western blotting market are increasing initiatives by private and government bodies, expansion of biotechnology industry, and automation in western blot techniques. Rising prevalence of diseases like Lyme and HIV, coupled with the need for effective diagnosis and improved treatment is further augmenting the market outlook.
Asia Pacific western blotting market was worth US $128.2 million in 2018 and is anticipated to register a growth rate of 5.9% over the analysis period to accrue US $210.92 million by 2027.
Speaking of end-user scope, Asia Pacific western blotting market from academic & research institutes segment is presumed to register accelerated expansion over the forecast timeline, owing to increasing number of biotechnology institutes across the region.
Companies that show prominence in the competitive landscape of Asia Pacific western blotting market are Abcam Plc., Rockland Immunochemicals, Inc., OriGene Technologies, Inc., LI-COR, Inc., Bio-Rad Laboratories, Inc., Perkin Elmer, Inc., Cell Signaling Technology, Inc., General Electric, Merck KGaA, and Thermo Fisher Scientific, Inc.